BOSTON SCIENTIFIC CORP
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
COLOR EXTRAPOLATION FROM MONOCHROME IMAGE SENSOR
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
How Far Can BSX Stock Swing After Losing More Than Half Its Value?
Boston Scientific (BSX) stock has fallen 55.5% over the past twelve months, and at $43.72 it trades barely above its 52-week low of $42.63. The options market now prices a likely one-year range from $28.46 to $67.16 a share. That band is wide, but it is close to how much the stock has already been moving.
Why BSX Stock Lost More Than Half Its Value While Sales Kept Rising
Boston Scientific (BSX) has fallen about 54% since late December 2025, and it now sits at $43.91, just above a 52-week low of $42.63. Device peers were mixed over the same nine months: Abbott lost about 17%, Medtronic barely moved, and Johnson & Johnson rose about 32%. The market repriced Boston Scientific's growth rate after management concentrated its guidance cut in two core product lines.
Has BSX Stock Finally Hit Bottom?
Boston Scientific (BSX) stock has fallen about 57% over the past year, to about $45. The shares now sell for 3.2 times trailing sales, hovering near their decade-long historical trough of roughly 3.0 times and well off their 8.6 high.
Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.
Boston Scientific Corporation (NYSE:BSX) fell 2.3% in early trading on September 8, 2026, after disclosing that an August 25 cyberattack disrupted manufacturing and shipping. The company stated it is unlikely to meet its previously issued third-quarter and full-year 2026 guidance for net sales and adjusted earnings per share. Though operations have since resumed, the incident […]
Is This BSX Stock Pullback Worth The Patience?
Boston Scientific (BSX) trades at about $43, roughly 17% below the recent high it set on 19th Aug, 2026. Its own history with sharp drops is encouraging. That history does not cover a cyberattack it says is likely to hit its 2026 results, and the stock is down about 60% over the past twelve months. Start with the history.
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Boston Scientific fully restores operations after cyberattack
CEO Mike Mahoney gave more details at a Thursday investor conference, saying the company likely lost orders while its plants and distribution centers were shut down.
Boston Scientific: $43 Finally Prices In A Bad 2026
Boston Scientific warns that the cyberattack will hit Q3, but recovery may delayânot loseârevenue. Click here to read this latest analysis of BSX stock.
Why Boston Scientific (BSX) Dipped More Than Broader Market Today
Boston Scientific (BSX) reached $43.1 at the closing of the latest trading day, reflecting a -4.14% change compared to its last close.
Boston Scientific Corporation (BSX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Boston Scientific Corporation (BSX) Wells Fargo 21st Annual Healthcare Conference September 10, 2026 8:00 AM EDTCompany ParticipantsMichael Mahoney -...
Congressional Trades in $BSX
Insider Trades (Form 4)
Morano Susan E
O'Connor Padraig Andrew
Butcher Arthur C
Key People
Morano Susan E
Director
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
OConnor Padraig Andrew
EVP, Global Operations
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
Political Giving
$181,000 given to 43 candidates across 97 disclosed contributions (FEC Schedule A).
Katherine M. Clark
Adrian Smith
Carol Devine Miller
Bradley S. Schneider
Gus M. Bilirakis
Terri A. Sewell
Lori Trahan
Markwayne Mullin
Suzan K. DelBene
John Cornyn
Bill Cassidy
Blake Moore
Darin McKay LaHood
Kim Schrier
Lisa McClain
Ruben Gallego
Kevin Hern
James E Hon Banks
John Curtis
Scott H. Peters
+ 23 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro